
Chartanalyse Cooper Companies: Qualitätsaktie im Aufwind
Die Aktie bietet mittelfristig fast 30 % Potenzial.
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Die Aktie bietet mittelfristig fast 30 % Potenzial.
The hedge fund will push Cooper to improve how it allocates capital in order to boost returns, the WSJ said.
The Cooper Companies (COO) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for some clues.
Zacks.com users have recently been watching Lowes (LOW) quite a bit. Thus, it is worth knowing the facts that could determine the stocks prospects.